The Scientific Registry of Transplant Recipients (SRTR) builds riskadjustment models for posttransplant graft and patient survival. Risk adjustment ensures that recipients with more observed comorbid conditions and/or lower-quality donors do not generate worse adjusted posttransplant evaluations.
| INTRODUC TI ON
The Scientific Registry of Transplant Recipients (SRTR) builds riskadjustment models for posttransplant graft and patient survival. Risk adjustment ensures that recipients with more observed comorbid conditions and/or lower-quality donors do not generate worse adjusted posttransplant evaluations. 1 Risk-adjustment models are especially important for 1-year posttransplant graft and patient survival because these outcomes are important in public reporting and regulatory review. [2] [3] [4] [5] The quality of risk adjustment in transplantation is commonly measured by the C-statistic. 4, 6, 7 The C-statistic measures the ability of the risk-adjustment models to accurately order, for example, graft failure times, and is likely popular due to its relatively intuitive interpretation.
Specifically, the C-statistic is interpreted as the probability that the risk-adjustment model correctly identified the graft that failed first among 2 randomly selected recipients. For example, a C-statistic of 0.5 implies that the risk-adjustment model correctly identified the graft that failed first 50% of the time (ie, no better than a coin-flip). In contrast, a C-statistic of 1.0 implies that the risk-adjustment model always correctly identified the graft that failed first. As a consequence, in the context of 1-year posttransplant survival, a C-statistic of 1.0 implies that every graft failure prior to 1 year had a higher predicted risk of failure than every graft failure after 1 year. However, from a statistical point of view, the C-statistic depends on the variability in risk for individual transplants; that is, given a correctly specified model, a high C-statistic requires more variability among recipients in, for example, the 1-year probability of graft survival than a lower C-statistic. 8 In previous research, the C-statistic had, at best, a modest association with the accuracy of cardiovascular report cards derived from logistic regression; that is, the C-statistic provided limited information on the validity of risk adjustment. 9 The Lastly, accurate estimation of program quality depended more on the effective sample size at each program than on the C-statistic of the risk-adjustment model. 10 Despite their dependence on the variability in risk for individual transplants, the C-statistics for the posttransplant models published by SRTR are commonly cited as a reason to distrust estimated program-specific hazard ratios (HRs) in the context of both public reporting and regulatory review. 6, 7 Thus, we extended the previous research to transplantation to better inform the discussion about the importance of the C-statistic in evaluating the quality of risk adjustment. Specifically, a Monte Carlo simulation study evaluated the relationship between the C-statistic and the accuracy of estimated program-specific HRs and associated metrics (eg, accuracy of regulatory identification). The simulation study was designed to mimic, to the extent possible, SRTR's process for estimating programspecific HRs, and the study was designed with similar characteristics to the posttransplant evaluations of 1-year graft survival for deceased donor kidney-alone recipients.
| ME THODS
This study used SRTR data. The SRTR data system includes data on all donors, waitlisted candidates, and transplant recipients in the The simulations were run in R v3.4.3 19 and used the "survival" 20 and "dplyr" 21 packages. Code for the simulation study is available at https://github.com/SRTRdevhub/C_Statistic_Github.
| RE SULTS

| Summary measures for the simulation study
The C-statistic increased with higher variability in risk for individual transplants, even though each model was correctly specified (Table 1 ). The C-statistic for the scenario with variability estimated from the current models (s = 1) was most similar to the value ob- (Table 2 ).
| Association with MSE
Within each stratum of expected events, the MSE was constant across the range of C-statistics ( Figure 1 ). As expected, the MSE was highest for programs with <3 expected events and lowest for programs with ≥10 expected events. The pattern was similar in the presence of unmeasured risk factors. In fact, the most significant impact of unmeasured risk factors was a higher overall MSE, especially for programs with >10 expected events. Thus, the C-statistic was not associated with the MSE of program-specific HRs, even in the presence of unadjusted risks. In other words, the C-statistic provided no information on the accuracy of program-specific HRs.
| Association with the program assignment in the 5-tier system
Spearman's rho between tier assignment and true programspecific HRs was independent of the C-statistic ( 
| Association with CMS and MPSC flagging
The probability that programs flagged by CMS had true HRs >1.25
was independent of the C-statistic (Figure 3 ). The probabilities were approximately 68% and 95% for programs with <3 and >10 expected events, respectively. For programs flagged by the MPSC, the probability that the true HR was >1.25 surprisingly decreased for the highest C-statistic. The probabilities were approximately 52% and 80%
for programs with <3 and >10 expected events, respectively. In the presence of unmeasured confounding, the probabilities decreased for both the CMS and MPSC flags, and the decrease was largest for programs with >10 expected events and smallest for programs with <3 expected events. Importantly, the probabilities were lower for the MPSC flag than for the CMS flag because the MPSC criteria are uniformly less stringent than the CMS criteria. 
| D ISCUSS I ON
Correctly specified models can have low or high C-statistics. In the simulation study, the C-statistic for the same correctly specified model ranged from 0.57 for the scenario with the lowest variability in risk for individual transplants to 0.97 for the scenario with the highest variability ( Table 2 ). This illustrates that the C-statistic cannot distinguish between a correctly specified model and the underlying variability in risk for individual transplants. Thus, the C-statistic cannot identify a correctly specified model.
Despite this limitation, the C-statistic has potential utility in comparing the performance of different models for the same data set, although such comparisons must account for the issue of overfitting with, for example, cross-validation. 12 However, even in these situations, the C-statistic suffers from important limitations. First, the C-statistic cannot identify miscalibrated models because ranked predictions ignore the magnitude of the difference between observed and expected outcomes. Second, the traditional C-statistic used for posttransplant survival models is not guaranteed to identify the "best" model for estimating the risk of, for example, 1-year graft survival. 22 In contrast, measures of predicted error do not suffer from these limitations. For example, the Brier Score is a measure of squared error at, for example, 1 year posttransplant, and will identify both miscalibrated models and the "best" model for predicting graft survival at 1 year.
Importantly, there exists no measure of risk discrimination or predicted error that can identify a correctly specified model, because they all depend on unknown characteristics of the data. For example,
TA B L E 2 Comparison of the operating characteristics of the scenarios with and without unadjusted risks
Value of s The unadjusted risks had a variance equal to half the variance of the program-specific hazard ratios. The s value controls the level of variability in the risk for individual transplants. Each simulation scenario was specifically designed to have the same overall 1-year survival percentage. The simulation study also demonstrated that the C-statistic does not detect unadjusted risks. The C-statistics for simulations with and without unadjusted risk factors were not meaningfully different (Table 2) program-specific HRs derived from a single risk-adjustment model. This is fundamentally related to the fact that the measures depend on unknown characteristics of the data. Thus, correctly specified models can have low C-statistics due to low variability in recipient-level risk, or high Brier Scores due to high residual variability.
However, in either situation, program-specific HRs can be accurately estimated because the model may be correctly specified.
Rather than rely on heuristic appeals to "low" C-statistics, All evaluated metrics of program evaluation accuracy were worse in the presence of unadjusted risks. The MSE increased, the tier correlation with the true HR weakened, and the probability that a flagged program had an HR >1.25 decreased. So, the simulation study does not justify refusing opportunities to build better models.
Instead, it demonstrates the importance of assessing the quality of risk adjustment through a critical evaluation of the underlying statistical methodology. For example, SRTR currently builds risk-adjustment models by considering a wide range of potential risk factors and uses flexible linear splines to estimate the effect of continuous risk factors. 4 While a wide range of risk factors is considered, the modeling approach relies on the proportional hazards assumption, and accounting for nonproportional hazards may improve the risk adjustment (eg, the effect of bilateral versus single lung transplant is known to have nonproportional hazards). 24 Alternatively, better integration of interactions could also improve risk adjustment. 25 In other words, a better understanding of the effect of violated assumptions on the performance of current models would help develop better risk adjustment.
Despite following the SRTR process for estimating posttransplant program-specific HRs, this simulation study has limitations. First, survival times were simulated from a proportional hazards model. Thus, the risk-adjustment model in the simulation was correctly specified, which is unlikely to happen in practice. Second, we assumed a normal distribution of recipient-level risk. Different distributions may change the C-statistic, assuming the same level of variability in recipient-level risk, but seems unlikely to affect the association between the C-statistic and the accuracy of program-specific HRs.
We illustrated that the C-statistic of risk-adjustment models provides no information on accuracy of program-specific HRs, categorization of programs into the 5-tier system, 5 identification of programs for regulatory review, or presence of unadjusted risk factors.
Instead, a program's volume (ie, the number of expected events) was the most important determinant of the accuracy of programspecific HRs. 
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